This article originally appeared on AKASA’s website.
AIM Research, a premier AI and data science market research firm, identified AKASA as a standout company due to its groundbreaking solutions that merge advanced AI technology with the complexities of healthcare operations.
This respected distinction highlights AKASA’s innovative use of generative AI (GenAI) to streamline revenue cycle management for healthcare providers, improving revenue yield and enhancing operational efficiency. AKASA is one of only two companies on the list that serve the healthcare industry.
“We’re honored to be recognized for our work in GenAI,” said Malinka Walaliyadde, CEO and co-founder of AKASA. “It is a testament to the dedication and innovation of our team. We’re using the best technology available to solve the most complex problems of the revenue cycle.” Click here to continue>>
News From Our Partners
